FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979778936> ?p ?o ?g. }

• W2979778936 endingPage "42" @default.
• W2979778936 startingPage "31" @default.
• W2979778936 abstract "Abstract Aims The aim of the present study was to establish the safety and efficacy profile of prasugrel and ticagrelor in real-life acute coronary syndrome (ACS) patients with renal dysfunction. Methods and results All consecutive patients from RENAMI (REgistry of New Antiplatelets in patients with Myocardial Infarction) and BLEEMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registries were stratified according to estimated glomerular filtration rate (eGFR) lower or greater than 60 mL/min/1.73 m2. Death and myocardial infarction (MI) were the primary efficacy endpoints. Major bleedings (MBs), defined as Bleeding Academic Research Consortium bleeding types 3 to 5, constituted the safety endpoint. A total of 19 255 patients were enrolled. Mean age was 63 ± 12; 14 892 (77.3%) were males. A total of 2490 (12.9%) patients had chronic kidney disease (CKD), defined as eGFR &lt;60 mL/min/1.73 m2. Mean follow-up was 13 ± 5 months. Mortality was significantly higher in CKD patients (9.4% vs. 2.6%, P &lt; 0.0001), as well as the incidence of reinfarction (5.8% vs. 2.9%, P &lt; 0.0001) and MB (5.7% vs. 3%, P &lt; 0.0001). At Cox multivariable analysis, potent P2Y12 inhibitors significantly reduced the mortality rate [hazard ratio (HR) 0.82, 95% confidence interval (CI) 0.54–0.96; P = 0.006] and the risk of reinfarction (HR 0.53, 95% CI 0.30–0.95; P = 0.033) in CKD patients as compared to clopidogrel. The reduction of risk of reinfarction was confirmed in patients with preserved renal function. Potent P2Y12 inhibitors did not increase the risk of MB in CKD patients (HR 1.00, 95% CI 0.59–1.68; P = 0.985). Conclusion In ACS patients with CKD, prasugrel and ticagrelor are associated with lower risk of death and recurrent MI without increasing the risk of MB." @default.
• W2979778936 created "2019-10-18" @default.
• W2979778936 creator A5001655177 @default.
• W2979778936 creator A5001666794 @default.
• W2979778936 creator A5002020543 @default.
• W2979778936 creator A5003043245 @default.
• W2979778936 creator A5004441247 @default.
• W2979778936 creator A5004909289 @default.
• W2979778936 creator A5005247086 @default.
• W2979778936 creator A5005503597 @default.
• W2979778936 creator A5007122223 @default.
• W2979778936 creator A5011133072 @default.
• W2979778936 creator A5012203620 @default.
• W2979778936 creator A5013276594 @default.
• W2979778936 creator A5014295530 @default.
• W2979778936 creator A5014606969 @default.
• W2979778936 creator A5016442751 @default.
• W2979778936 creator A5016879313 @default.
• W2979778936 creator A5018178530 @default.
• W2979778936 creator A5020113982 @default.
• W2979778936 creator A5024310729 @default.
• W2979778936 creator A5026748981 @default.
• W2979778936 creator A5026989499 @default.
• W2979778936 creator A5030636329 @default.
• W2979778936 creator A5033242180 @default.
• W2979778936 creator A5035250509 @default.
• W2979778936 creator A5035928297 @default.
• W2979778936 creator A5038577262 @default.
• W2979778936 creator A5040546862 @default.
• W2979778936 creator A5043214579 @default.
• W2979778936 creator A5045166344 @default.
• W2979778936 creator A5045256592 @default.
• W2979778936 creator A5047767403 @default.
• W2979778936 creator A5048719508 @default.
• W2979778936 creator A5053009111 @default.
• W2979778936 creator A5055478790 @default.
• W2979778936 creator A5055700349 @default.
• W2979778936 creator A5058053974 @default.
• W2979778936 creator A5060616979 @default.
• W2979778936 creator A5062578224 @default.
• W2979778936 creator A5065340826 @default.
• W2979778936 creator A5065794256 @default.
• W2979778936 creator A5069315151 @default.
• W2979778936 creator A5069850719 @default.
• W2979778936 creator A5071002812 @default.
• W2979778936 creator A5071397983 @default.
• W2979778936 creator A5072084373 @default.
• W2979778936 creator A5074392218 @default.
• W2979778936 creator A5076996249 @default.
• W2979778936 creator A5078024289 @default.
• W2979778936 creator A5079850281 @default.
• W2979778936 creator A5081353323 @default.
• W2979778936 creator A5083236244 @default.
• W2979778936 creator A5086003905 @default.
• W2979778936 creator A5087939829 @default.
• W2979778936 creator A5088302186 @default.
• W2979778936 creator A5089353975 @default.
• W2979778936 date "2019-09-12" @default.
• W2979778936 modified "2023-10-17" @default.
• W2979778936 title "P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects" @default.
• W2979778936 cites W1194331807 @default.
• W2979778936 cites W1524822070 @default.
• W2979778936 cites W1972679886 @default.
• W2979778936 cites W2005172918 @default.
• W2979778936 cites W2024656127 @default.
• W2979778936 cites W2027623711 @default.
• W2979778936 cites W2030060276 @default.
• W2979778936 cites W2039230140 @default.
• W2979778936 cites W2055864845 @default.
• W2979778936 cites W2073742622 @default.
• W2979778936 cites W2082069148 @default.
• W2979778936 cites W2108650851 @default.
• W2979778936 cites W2114102173 @default.
• W2979778936 cites W2120309051 @default.
• W2979778936 cites W2122779695 @default.
• W2979778936 cites W2140501627 @default.
• W2979778936 cites W2169387542 @default.
• W2979778936 cites W2298041777 @default.
• W2979778936 cites W2331820709 @default.
• W2979778936 cites W2555022685 @default.
• W2979778936 cites W2600985212 @default.
• W2979778936 cites W2738907084 @default.
• W2979778936 cites W2740765498 @default.
• W2979778936 cites W2744585802 @default.
• W2979778936 cites W2786978571 @default.
• W2979778936 cites W2790869523 @default.
• W2979778936 cites W2899881514 @default.
• W2979778936 cites W2941788597 @default.
• W2979778936 cites W4211025575 @default.
• W2979778936 cites W4238277289 @default.
• W2979778936 doi "https://doi.org/10.1093/ehjcvp/pvz048" @default.
• W2979778936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31511896" @default.
• W2979778936 hasPublicationYear "2019" @default.
• W2979778936 type Work @default.
• W2979778936 sameAs 2979778936 @default.
• W2979778936 citedByCount "35" @default.
• W2979778936 countsByYear W29797789362020 @default.
• W2979778936 countsByYear W29797789362021 @default.

• next